← All Sponsors

SPONSOR

Rapport Therapeutics Inc.

Total Trials

2

Recruiting

2

Phases

Phase 2

Conditions studied: Focal Epilepsy Epilepsy Refractory Focal Epilepsy Seizure Focal Seizure Focal Onset Seizure Bipolar 1 Disorder

NCT07219407 Phase 2

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

NCT07046494 Phase 2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Bipolar 1 Disorder